Wednesday, August 13, 2025 | 05:28 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Listed MNCs remain immune to coronavirus outbreak as m-cap rises to 15%

With combined market capitalisation of Rs 13.8 trillion, 74 Indian subsidiaries of global multinationals are now ahead of state-owned listed companies

Representative Image
premium

Analysts attribute the growing heft of MNCs on the bourses to their strong resilience in the face of a sharp sell-off on Dalal Street over fears of the pandemic-induced economic disruption.

Krishna Kant Mumbai
As the economic crisis due to Covid-19 holds dominion over India Inc, listed Indian subsidiaries of multinational companies (MNCs) continue to pull ahead of their domestic peers.
 
Listed MNCs now account for 14.6 per cent of the combined m-cap of all listed companies in the country. The share is the highest in at least six years and up from 10.9 per cent at the end of March last year.
 
They accounted for 9.3 per cent of India’s m-cap at the end of March 2014.
 
With combined m-cap of Rs 13.8 trillion, 74 Indian subsidiaries of global multinationals are now ahead